Veterinary Medicines

ITA ND+IB vakcina A.U.V.

Authorised
  • Newcastle disease virus, Inactivated
  • Avian infectious bronchitis virus, Inactivated
Download as PDF

Product identification

Medicine name:
ITA ND+IB vakcina A.U.V.
Active substance:
  • Newcastle disease virus, Inactivated
  • Avian infectious bronchitis virus, Inactivated
Target species:
  • Chicken (hen)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Newcastle disease virus, Inactivated
    50.00
    50% Protective Dose
    /
    1.00
    unit(s)/dose
  • Avian infectious bronchitis virus, Inactivated
    6.00
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (hen)
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken (hen)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA10
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laprovet Hungary Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laprovet Hungary Állatgyógyászati Kft.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."